Concepts (138)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Zebrafish | 15 | 2023 | 310 | 4.100 |
Why?
|
Neoplastic Stem Cells | 4 | 2019 | 143 | 1.320 |
Why?
|
Genome | 3 | 2023 | 372 | 1.220 |
Why?
|
Haplotypes | 3 | 2023 | 639 | 1.070 |
Why?
|
Zebrafish Proteins | 5 | 2016 | 145 | 1.060 |
Why?
|
Genes, MHC Class I | 2 | 2014 | 48 | 0.950 |
Why?
|
Hematopoiesis | 4 | 2019 | 164 | 0.820 |
Why?
|
Side-Population Cells | 1 | 2019 | 1 | 0.680 |
Why?
|
Hematopoietic Stem Cell Transplantation | 2 | 2019 | 878 | 0.650 |
Why?
|
Precursor T-Cell Lymphoblastic Leukemia-Lymphoma | 2 | 2017 | 53 | 0.650 |
Why?
|
Wnt Signaling Pathway | 1 | 2019 | 94 | 0.630 |
Why?
|
Histocompatibility Antigens Class I | 2 | 2016 | 203 | 0.630 |
Why?
|
Cell Separation | 2 | 2017 | 196 | 0.600 |
Why?
|
Cell Transformation, Neoplastic | 1 | 2019 | 428 | 0.560 |
Why?
|
Cysteine Endopeptidases | 1 | 2016 | 87 | 0.560 |
Why?
|
Flow Cytometry | 2 | 2017 | 680 | 0.540 |
Why?
|
Anemia, Hemolytic, Congenital Nonspherocytic | 1 | 2015 | 2 | 0.540 |
Why?
|
Pyruvate Metabolism, Inborn Errors | 1 | 2015 | 2 | 0.540 |
Why?
|
Anemia, Neonatal | 1 | 2015 | 5 | 0.530 |
Why?
|
Pyruvate Kinase | 1 | 2015 | 13 | 0.530 |
Why?
|
Leukemoid Reaction | 1 | 2015 | 5 | 0.520 |
Why?
|
Skin Diseases, Vesiculobullous | 1 | 2015 | 18 | 0.510 |
Why?
|
Down Syndrome | 1 | 2015 | 54 | 0.500 |
Why?
|
Precursor Cell Lymphoblastic Leukemia-Lymphoma | 1 | 2019 | 375 | 0.500 |
Why?
|
Cell Differentiation | 2 | 2019 | 1471 | 0.490 |
Why?
|
Immunoglobulins, Intravenous | 2 | 2017 | 66 | 0.480 |
Why?
|
Gene Expression | 2 | 2013 | 1286 | 0.410 |
Why?
|
Animals | 15 | 2023 | 26650 | 0.390 |
Why?
|
Biomarkers, Tumor | 1 | 2019 | 1465 | 0.380 |
Why?
|
Hemolysis | 1 | 2009 | 61 | 0.350 |
Why?
|
Tretinoin | 1 | 2010 | 126 | 0.350 |
Why?
|
Biological Evolution | 1 | 2016 | 919 | 0.330 |
Why?
|
Basic Helix-Loop-Helix Transcription Factors | 1 | 2010 | 168 | 0.330 |
Why?
|
Gene Expression Regulation, Developmental | 3 | 2012 | 649 | 0.300 |
Why?
|
Phylogeny | 4 | 2022 | 1137 | 0.300 |
Why?
|
Proto-Oncogene Proteins | 1 | 2010 | 645 | 0.280 |
Why?
|
Mutation | 2 | 2015 | 3978 | 0.270 |
Why?
|
Chromosomes | 1 | 2023 | 96 | 0.220 |
Why?
|
Major Histocompatibility Complex | 2 | 2014 | 81 | 0.210 |
Why?
|
Hemoglobins | 2 | 2015 | 179 | 0.210 |
Why?
|
BRCA1 Protein | 1 | 2023 | 200 | 0.210 |
Why?
|
Hematologic Diseases | 2 | 2017 | 79 | 0.210 |
Why?
|
Receptors, Immunologic | 1 | 2022 | 135 | 0.200 |
Why?
|
Exons | 1 | 2023 | 452 | 0.200 |
Why?
|
Transcriptome | 2 | 2016 | 580 | 0.200 |
Why?
|
Hematopoietic Stem Cells | 2 | 2015 | 292 | 0.190 |
Why?
|
Disease Models, Animal | 3 | 2017 | 2240 | 0.190 |
Why?
|
Recombinational DNA Repair | 1 | 2020 | 9 | 0.190 |
Why?
|
Gene Editing | 1 | 2020 | 42 | 0.180 |
Why?
|
CRISPR-Cas Systems | 1 | 2020 | 70 | 0.180 |
Why?
|
Infant, Newborn | 2 | 2015 | 2380 | 0.170 |
Why?
|
Animals, Genetically Modified | 2 | 2017 | 182 | 0.170 |
Why?
|
Infant | 3 | 2017 | 3049 | 0.160 |
Why?
|
RNA Splicing | 1 | 2019 | 142 | 0.150 |
Why?
|
Lymphohistiocytosis, Hemophagocytic | 1 | 2017 | 18 | 0.150 |
Why?
|
Tumor Cells, Cultured | 1 | 2019 | 1041 | 0.150 |
Why?
|
Cloning, Organism | 1 | 2016 | 19 | 0.140 |
Why?
|
Benzimidazoles | 1 | 2017 | 112 | 0.140 |
Why?
|
Proteasome Endopeptidase Complex | 1 | 2016 | 100 | 0.140 |
Why?
|
Protein Isoforms | 1 | 2016 | 272 | 0.130 |
Why?
|
Amino Acid Sequence | 2 | 2022 | 2065 | 0.130 |
Why?
|
Antigen Presentation | 1 | 2016 | 210 | 0.130 |
Why?
|
Blood Transfusion | 1 | 2015 | 157 | 0.120 |
Why?
|
Gestational Age | 1 | 2015 | 312 | 0.120 |
Why?
|
GATA1 Transcription Factor | 2 | 2012 | 18 | 0.120 |
Why?
|
Conserved Sequence | 1 | 2013 | 210 | 0.110 |
Why?
|
High-Throughput Nucleotide Sequencing | 1 | 2016 | 456 | 0.110 |
Why?
|
Sequence Alignment | 1 | 2013 | 352 | 0.110 |
Why?
|
Embryo, Nonmammalian | 2 | 2012 | 193 | 0.110 |
Why?
|
Locus Control Region | 1 | 2012 | 3 | 0.110 |
Why?
|
Gene Regulatory Networks | 1 | 2015 | 297 | 0.110 |
Why?
|
Globins | 1 | 2012 | 31 | 0.110 |
Why?
|
Genetic Linkage | 1 | 2013 | 623 | 0.100 |
Why?
|
Humans | 10 | 2023 | 85777 | 0.100 |
Why?
|
Chimerism | 1 | 2011 | 37 | 0.100 |
Why?
|
Diagnosis, Differential | 1 | 2015 | 1561 | 0.100 |
Why?
|
T-Cell Acute Lymphocytic Leukemia Protein 1 | 1 | 2010 | 4 | 0.090 |
Why?
|
Chromosome Mapping | 1 | 2013 | 1073 | 0.090 |
Why?
|
Sequence Analysis, DNA | 1 | 2013 | 853 | 0.090 |
Why?
|
Polyradiculoneuropathy | 1 | 2009 | 8 | 0.090 |
Why?
|
Models, Animal | 1 | 2011 | 264 | 0.090 |
Why?
|
Mucocutaneous Lymph Node Syndrome | 1 | 2009 | 27 | 0.090 |
Why?
|
In Situ Hybridization | 1 | 2010 | 310 | 0.090 |
Why?
|
Neoplasm Transplantation | 1 | 2010 | 393 | 0.080 |
Why?
|
Molecular Sequence Data | 1 | 2013 | 3034 | 0.080 |
Why?
|
Leukemia, Myeloid, Acute | 1 | 2015 | 763 | 0.080 |
Why?
|
Transplantation Conditioning | 1 | 2011 | 373 | 0.080 |
Why?
|
Neoplasms | 1 | 2023 | 2895 | 0.080 |
Why?
|
Models, Genetic | 1 | 2013 | 929 | 0.080 |
Why?
|
Acute Disease | 1 | 2009 | 827 | 0.080 |
Why?
|
Purpura, Thrombocytopenic, Idiopathic | 1 | 2006 | 12 | 0.070 |
Why?
|
Antirheumatic Agents | 1 | 2006 | 54 | 0.070 |
Why?
|
Homeodomain Proteins | 1 | 2010 | 538 | 0.070 |
Why?
|
Polymorphism, Single Nucleotide | 1 | 2013 | 2354 | 0.060 |
Why?
|
Gene Expression Regulation | 1 | 2013 | 1928 | 0.060 |
Why?
|
Autoimmune Diseases | 1 | 2006 | 241 | 0.060 |
Why?
|
Child | 2 | 2017 | 6930 | 0.060 |
Why?
|
Germ Cells | 1 | 2023 | 126 | 0.060 |
Why?
|
BRCA2 Protein | 1 | 2023 | 158 | 0.050 |
Why?
|
Child, Preschool | 1 | 2009 | 3612 | 0.050 |
Why?
|
Immunoglobulins | 1 | 2022 | 148 | 0.050 |
Why?
|
Germ-Line Mutation | 1 | 2023 | 330 | 0.050 |
Why?
|
Nitroreductases | 1 | 2020 | 4 | 0.050 |
Why?
|
Templates, Genetic | 1 | 2020 | 34 | 0.050 |
Why?
|
INDEL Mutation | 1 | 2020 | 30 | 0.050 |
Why?
|
Indicators and Reagents | 1 | 2020 | 72 | 0.050 |
Why?
|
Mammals | 1 | 2022 | 227 | 0.050 |
Why?
|
Melanocytes | 1 | 2020 | 56 | 0.050 |
Why?
|
Green Fluorescent Proteins | 1 | 2020 | 306 | 0.040 |
Why?
|
Signal Transduction | 1 | 2010 | 3264 | 0.040 |
Why?
|
Fluorescent Dyes | 1 | 2020 | 242 | 0.040 |
Why?
|
Female | 3 | 2017 | 44216 | 0.040 |
Why?
|
Adolescent | 1 | 2009 | 8959 | 0.040 |
Why?
|
RNA | 1 | 2020 | 560 | 0.030 |
Why?
|
Genetic Predisposition to Disease | 1 | 2023 | 2271 | 0.030 |
Why?
|
Male | 2 | 2015 | 40652 | 0.030 |
Why?
|
NF-E2 Transcription Factor, p45 Subunit | 1 | 2012 | 1 | 0.030 |
Why?
|
Pediatrics | 1 | 2017 | 344 | 0.030 |
Why?
|
Genes, Switch | 1 | 2012 | 8 | 0.030 |
Why?
|
Drug Evaluation, Preclinical | 1 | 2010 | 104 | 0.020 |
Why?
|
Gene Expression Profiling | 1 | 2015 | 1388 | 0.020 |
Why?
|
Microscopy, Fluorescence | 1 | 2010 | 425 | 0.020 |
Why?
|
Body Patterning | 1 | 2010 | 210 | 0.020 |
Why?
|
Prognosis | 1 | 2015 | 3639 | 0.020 |
Why?
|
Risk Factors | 1 | 2017 | 5249 | 0.020 |
Why?
|
Algorithms | 1 | 2015 | 1824 | 0.020 |
Why?
|
Antibodies, Monoclonal, Murine-Derived | 1 | 2006 | 78 | 0.020 |
Why?
|
Lymphocyte Depletion | 1 | 2006 | 97 | 0.020 |
Why?
|
Rituximab | 1 | 2006 | 116 | 0.020 |
Why?
|
Genetic Testing | 1 | 2010 | 533 | 0.020 |
Why?
|
Cyclosporine | 1 | 2006 | 235 | 0.020 |
Why?
|
Tacrolimus | 1 | 2006 | 373 | 0.020 |
Why?
|
United States | 1 | 2017 | 6580 | 0.020 |
Why?
|
Treatment Outcome | 1 | 2017 | 7830 | 0.020 |
Why?
|
Image Processing, Computer-Assisted | 1 | 2010 | 1205 | 0.010 |
Why?
|
Phenotype | 1 | 2010 | 2389 | 0.010 |
Why?
|
Transcription Factors | 1 | 2010 | 1580 | 0.010 |
Why?
|
Antibodies, Monoclonal | 1 | 2006 | 1379 | 0.010 |
Why?
|